Top Markets
Coin of the day
Elicio Therapeutics, Inc. Elicio Therapeutics, Inc.

Elicio Therapeutics, Inc.

ELTX
Rang în acțiuni #24601
Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to... Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating a diverse array of innovative immunotherapies for the treatment of various cancers and other diseases. The company's primary experimental drug, ELI-002, is an AMP therapeutic vaccine specifically formulated to target KRAS-driven cancers. Its development portfolio also encompasses ELI-004, an AMP-modified CpG adjuvant that forms part of ELI-002; ELI-007, a lymph node-targeted AMP-peptide vaccine addressing mutant BRAF-driven cancers; and ELI-008, a multivalent lymph node-targeted AMP-peptide vaccine for cancers expressing mutant TP53. Furthermore, Elicio is advancing ELI-005, a vaccine candidate for preventing COVID-19, and ELI-011 for hematological malignancies. Another program, ELI-012, is an mKRAS TCR T cell AMP-lifier designed for combined use with mKRAS-targeted TCR T cell therapy against mKRAS-driven cancers. The company's operations are headquartered in Boston, Massachusetts.
Preț acțiune
$3.09
Capitalizare de piață
$58.82M
Schimbare (1 zi)
0.33%
Schimbare (1 an)
-73.01%
Țară
US
Tranzacționează Elicio Therapeutics, Inc. (ELTX)

Categorie

Istoricul spliturilor pentru Elicio Therapeutics, Inc. (ELTX)
Acțiunea Elicio Therapeutics, Inc. (simbol: ELTX) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Aug 21, 2026.
O acțiune ELTX cumpărată înainte de Aug 21, 2026 este echivalentă astăzi cu 0 acțiuni ELTX.
Listă splituri acțiuni
An Split Multiplu Multiplu cumulativ
Nu sunt suficiente date pentru perioada selectată.
Splituri pentru companii similare sau competitori
Companie Număr total de splituri Multiplu cumulativ Țara
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH